Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001801266-20-000001
Filing Date
2020-02-05
Accepted
2020-02-05 17:00:01
Documents
1
Effectiveness Date
2020-02-05
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 8137
  Complete submission text file 0001801266-20-000001.txt   9147
Mailing Address 15 LINCOLN ROAD BROOKLINE MA 02445
Business Address 15 LINCOLN ROAD BROOKLINE MA 02445 781-608-3996
Rgenta Therapeutics, Inc. (Filer) CIK: 0001801266 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-359879 | Film No.: 20579571